Canada markets close in 2 hours 14 minutes

Syros Pharmaceuticals Inc (0S90.MU)

Munich - Munich Delayed Price. Currency in EUR
Add to watchlist
5.300.00 (0.00%)
As of 08:10AM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
6,982
9,936
14,880
23,488
15,093
-
Operating Expenses
Research Development
104,047
108,153
111,944
99,872
76,065
-
Selling General and Administrative
27,143
28,282
29,299
23,036
21,325
-
Total Operating Expenses
131,190
136,435
141,243
122,908
97,390
-
Operating Income or Loss
-124,208
-126,499
-126,363
-99,420
-82,297
-
Interest Expense
5,217
5,127
4,134
3,907
1,792
-
Total Other Income/Expenses Net
-21,655
-39,764
33,711
16,682
-375
-
Income Before Tax
-144,493
-164,574
-94,654
-86,558
-84,038
-
Income from Continuing Operations
-144,493
-164,574
-94,654
-86,558
-84,038
-
Net Income
-144,493
-164,574
-94,654
-86,558
-84,038
-
Net Income available to common shareholders
-144,493
-164,574
-94,654
-86,558
-84,038
-
Basic EPS
0.85
-
-7.49
-13.84
-18.20
-18.80
Diluted EPS
0.85
-
-7.49
-13.84
-18.20
-18.80
Basic Average Shares
27,917
-
12,632
6,253
4,605
4,022
Diluted Average Shares
27,917
-
12,632
6,253
4,605
4,022